Cargando…
Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years
SIMPLE SUMMARY: In the next decades, the incidence of patients with glioblastoma (GBM) will markedly increase due to the growth of the elderly population. Despite the increasing incidence of GBM, elderly patients are frequently excluded from clinical studies and thus, only few data are available spe...
Autores principales: | Kiesel, Barbara, Wadiura, Lisa I., Mischkulnig, Mario, Makolli, Jessica, Sperl, Veronika, Borkovec, Martin, Freund, Julia, Lang, Alexandra, Millesi, Matthias, Berghoff, Anna S., Furtner, Julia, Woehrer, Adelheid, Widhalm, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657316/ https://www.ncbi.nlm.nih.gov/pubmed/34885227 http://dx.doi.org/10.3390/cancers13236119 |
Ejemplares similares
-
Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases
por: Mercea, Petra A., et al.
Publicado: (2021) -
5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers
por: Hosmann, Arthur, et al.
Publicado: (2021) -
Comparison of minimal detectable protoporphyrin IX concentrations with a loupe device and conventional 5-ALA fluorescence microscopy: an experimental study
por: Mischkulnig, Mario, et al.
Publicado: (2023) -
High Diagnostic Accuracy of Visible 5‐ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue
por: Wadiura, Lisa I., et al.
Publicado: (2020) -
Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
por: Hosmann, Arthur, et al.
Publicado: (2021)